Abstract:Objective:To explore the related factors for the clinical conversion of patients in clinical high risk(CHR).Methods:From February 2011 to May 2014, patients in the psychiatric clinics of Shanghai Mental Health Center were screened by the Structured Interview for Psychosis-risk Syndromes (SIPS) and re-assessed at a 2-year follow-up to measure their clinical symptoms and overall function. Patient′s prescribed medication were collected at the same time. Kaplan-Meyer survival analysis and Cox regression analysis were used to explore the relevant factors of CHR clinical conversion.Results:A total of 206 patients were enrolled, 38 patients were lost and/or withdrawn, and 168 patients completed the follow-up assessment. Survival analysis showed that positive symptoms (χ 2( df=1)=4.395, P=0.036), disorganize symptoms (χ 2( df=1)=4.425, P=0.035), total scores of psychosis-risk symptoms (χ 2( df=1)=3.881, P=0.049), overall function (χ 2( df=1)=5.961, P=0.015), antidepressant drugs (χ 2( df=1)=6.751, P=0.009), antipsychotics drugs (χ 2( df=1)=9.455, P=0.002), their corresponding dose (χ 2( df=1)=7.488, P=0.006) and length of treatment (χ 2( df=1)=5.368, P=0.021) were significantly related to clinical conversion for CHR. In addition, taking antipsychotics drugs may be a risk factor for clinical outcomes (β =0.844， P=0.007), while taking antidepressants may be a protective factor (β=-0.731, P=0.026). Conclusions:The clinical conversion of CHR patients may be related to the type of prescriptions. Further studies are warranted to examine the causal relationship in detail.

Analysis of related factors of clinical outcome in patients with clinical high risk syndromes